USA Mutuals Advisors’s ImmuCell ICCC Stock Holding History

USA Mutuals Advisors’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-471	Closed	-$3K	–	82
2016 Q2	$3K	Hold	471	–	–	﹤0.01%	93
2016 Q1	$3K	Hold	471	–	–	﹤0.01%	83
2015 Q4	$3K	Hold	471	–	–	﹤0.01%	93
2015 Q3	$3K	Buy	+471	New	+$3.84K	﹤0.01%	74

Other funds holding ICCC

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

EFS

Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

USA Mutuals Advisors's ICCC Position: Q3 2016 in Review

USA Mutuals Advisors sold out of ImmuCell (ICCC) in Q3 2016, closing a stake of 471 shares — an estimated $3K sold.

USA Mutuals Advisors first reported a position in ICCC in Q3 2015 and held it in 4 quarters. The position peaked at $3K in Q2 2016. 19 funds tracked by Wall St. Rank hold ICCC as of Q3 2016.

USA Mutuals Advisors reported no remaining ImmuCell position as of Q3 2016 after selling out during the quarter.
USA Mutuals Advisors sold 471 ImmuCell shares in Q3 2016, an estimated $3K.
USA Mutuals Advisors first reported a position in ImmuCell in Q3 2015 and held it in 4 quarters.
USA Mutuals Advisors's ImmuCell position peaked at $3K in Q2 2016.
19 funds tracked by Wall St. Rank held ImmuCell as of Q3 2016.

Based on USA Mutuals Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.